Dabrafenib–trametinib moves to the first line in low-grade glioma

Nature Reviews Clinical Oncology, Published online: 10 October 2023; doi:10.1038/s41571-023-00829-zDabrafenib–trametinib moves to the first line in low-grade glioma

Source: Nature Reviews Clinical Oncology - October 10, 2023 Category: Cancer & Oncology Authors: Diana Romero Source Type: research